Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Theranica Secures $45M Series C Funding

2022-08-29
MONTCLAIR, NJ, Theranica, a prescribed digital therapeutics company, announced the closing of a $45M Series C funding round.
Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other idiopathic pain conditions, announced the closing of its Series C funding round, with a first closing of $45 million.

Philadelphia-based New Rhein Healthcare Investors led the round, with wide participation of existing investors aMoon, Lightspeed Venture Partners, LionBird, Takoa Invest, and Corundum Open Innovation.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors